Sysmex ADR Gross Profit 2016-2025 | SSMXY
Sysmex ADR annual/quarterly gross profit history and growth rate from 2016 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Sysmex ADR gross profit for the quarter ending June 30, 2025 was $0.376B, a 13.6% increase year-over-year.
- Sysmex ADR gross profit for the twelve months ending June 30, 2025 was $1.128B, a 15.33% decline year-over-year.
- Sysmex ADR annual gross profit for 2025 was $1.813B, a 12.9% increase from 2024.
- Sysmex ADR annual gross profit for 2024 was $1.606B, a 0.43% increase from 2023.
- Sysmex ADR annual gross profit for 2023 was $1.599B, a 5.73% decline from 2022.
|
Sysmex ADR Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $1,813 |
| 2024 | $1,606 |
| 2023 | $1,599 |
| 2022 | $1,696 |
| 2021 | $1,390 |
| 2020 | $1,466 |
| 2019 | $1,454 |
| 2018 | $1,500 |
| 2017 | $1,266 |
| 2016 | $1,337 |
|
Sysmex ADR Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-06-30 | $376 |
| 2024-12-31 | |
| 2024-06-30 | $384 |
| 2023-06-30 | $368 |
| 2022-06-30 | $331 |
| 2021-06-30 | $381 |
| 2020-06-30 | $285 |
| 2019-06-30 | $336 |
| 2018-06-30 | $346 |
| 2017-06-30 | $314 |
| 2016-06-30 | $320 |
| 2016-03-31 | $585 |
| 2015-12-31 | $524 |
| 2015-09-30 | $526 |
| 2015-06-30 | $478 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.779B | $3.340B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.481B | 25.37 |
| Intuitive Surgical (ISRG) | United States | $203.217B | 79.51 |
| IDEXX Laboratories (IDXX) | United States | $56.427B | 56.04 |
| Edwards Lifesciences (EW) | United States | $48.931B | 32.81 |
| Alcon (ALC) | Switzerland | $38.902B | 26.29 |
| IQVIA Holdings (IQV) | United States | $38.074B | 21.23 |
| Mettler-Toledo (MTD) | United States | $28.219B | 33.02 |
| STERIS (STE) | Ireland | $25.657B | 26.49 |
| DexCom (DXCM) | United States | $25.593B | 35.28 |
| Waters (WAT) | United States | $23.382B | 30.92 |
| Hologic (HOLX) | United States | $16.684B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.692B | 0.00 |
| Globus Medical (GMED) | United States | $11.912B | 25.00 |
| Penumbra (PEN) | United States | $11.546B | 81.22 |
| Masimo (MASI) | United States | $7.566B | 24.24 |
| Glaukos (GKOS) | United States | $6.229B | 0.00 |
| Teleflex (TFX) | United States | $5.295B | 8.44 |
| TransMedics (TMDX) | United States | $4.668B | 55.30 |
| Veracyte (VCYT) | United States | $3.507B | 39.96 |
| LivaNova (LIVN) | United Kingdom | $3.422B | 18.49 |
| Alphatec Holdings (ATEC) | United States | $3.114B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.422B | 11.37 |
| Elekta AB (EKTAY) | Sweden | $2.119B | 19.83 |
| Artivion (AORT) | United States | $2.088B | 95.80 |
| PROCEPT BioRobotics (PRCT) | United States | $1.902B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.738B | 15.17 |
| UFP Technologies (UFPT) | United States | $1.664B | 21.98 |
| AxoGen (AXGN) | United States | $1.420B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.406B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.246B | 0.00 |
| IRadimed (IRMD) | United States | $1.215B | 57.87 |
| Integra LifeSciences Holdings (IART) | United States | $1.014B | 5.49 |
| OPKO Health (OPK) | United States | $1.013B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.914B | 0.00 |
| SiBone (SIBN) | United States | $0.824B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.700B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.620B | 36.04 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.619B | 0.00 |
| NeuroPace (NPCE) | United States | $0.547B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.546B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.522B | 10.41 |
| RxSight (RXST) | United States | $0.516B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.457B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.451B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.431B | 11.89 |
| ClearPoint Neuro (CLPT) | United States | $0.389B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.340B | 56.71 |
| Alpha Tau Medical (DRTS) | Israel | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.302B | 2.26 |
| Spectral Diagnostics (EDTXF) | Canada | $0.280B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.244B | 0.00 |
| 908 Devices (MASS) | United States | $0.242B | 0.00 |
| CVRx (CVRX) | United States | $0.236B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.197B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.176B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.166B | 0.00 |
| Solana (HSDT) | United States | $0.162B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.158B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.145B | 0.00 |
| LENSAR (LNSR) | United States | $0.134B | 0.00 |
| Accuray (ARAY) | United States | $0.112B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| Neuronetics (STIM) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.087B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.055B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.016B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.98 |